• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number ESP100-21
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Adult Respiratory Distress Syndrome (1696); Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446)
Event Date 08/29/2023
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2023, a 21mm epic aortic valve was implanted in a patient with a history of shortness of breath on exertion and severe aortic stenosis (ava 0.6cm2, vmax 4.1m/s, pgmax 67.0mmhg, pgmean 41.6mmhg).Max velo.=2.88 m/s, max pg=33.2mmh, mean pg=18.4mmhg, eoa=1.47 cm2, dvi=0.28, at=83msec.Ar(-).On (b)(6) 2023, echocardiograms were performed.Lv:dd/ds 40.2/27.7 dilation (-), asynergy(-)ef: 59.4% (teichholz method) 61.9% (simpson method) la: enlargement (-), obvious thrombosis (-) right cardiac system enlargement (-), right ventricular load (-) ivc enlargement (-) pleural effusion (-), pericardial effusion (-).The patient discharged from facility (b)(6) 2023.On (b)(6) 2023, the patients warfarin was discontinued.On (b)(6) 2023, the patient had sudden elevation of nt-probnp was observed in ambulatory follow-up, and dyspnea developed.Heart failure was suspected and diuretic increased.On (b)(6) 2023, an echocardiogram was performed.Max velo.=6.1 m/s, max pg=149 mmhg, mean pg=90 mmhg, eoa=0.4 cm2, dvi=0.12, at=160 msec.Aortic regurgitation trivial.On (b)(6) 2023, the patient respiratory distress improved.Thrombus valve was suspected, and the patient was admitted to the institution.Warfarin was reintroduced on (b)(6) 2023.Echocardiogram result on (b)(6) 2023 showed max velo.=2.8 m/s, max pg=31.4mmhg, mean pg=16.7mmhg, eoa=0.9 cm2, dvi=0.28, at=100 msec.Ar trivial and the patient was discharged home on (b)(6) 2023.When the patient visited outpatient department on (b)(6) 2023, patient¿s respiratory distress had disappeared.Nt-probnp 762.8.On (b)(6) 2023, the patient visited the outpatient department.Nt-probnp 1027.4 epic is not explanted, and the anticoagulation therapy is being carried out.The patient is recovering.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
An event of dyspnea, trivial aortic regurgitation and respiratory distress was reported.It was reported that thrombus was suspected on the valve.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.The device history record was also reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18387515
MDR Text Key331298004
Report Number2135147-2023-05674
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberESP100-21
Device Lot Number180730816
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
Patient Weight65 KG
-
-